LOXO Oncology Growth, Revenue, Number of Employees and Funding
Revenue & Financials
- LOXO Oncology's revenue is currently $23.4M per year.
- LOXO Oncology received $294.8M in venture funding in June 2017.
- LOXO Oncology's revenue per employee is $160000
- LOXO Oncology's total funding is $125.3M.
- LOXO Oncology has 146 Employees.
- LOXO Oncology grew their employee count by 74% last year.
- LOXO Oncology currently has 6 job openings.
What Is LOXO Oncology?
Loxo Oncology is a biopharmaceutical company dedicated to developing highly-selective medicines for patients with genomically defined cancers. Our pipeline is focused on treatments aimed at cancers caused by a single inappropriate DNA change, known as oncogenic drivers, which the tumor depends on for growth and survival. Loxo Oncology develops purpose-built medicines designed to selectively and potently inhibit these oncogenic drivers. We believe that this approach, combined with the use of tumor genomic testing to identify appropriate patients, will allow us to develop medicines that provide best-in-class disease control and safety and, ultimately, deliver on the promise of precision medicine. We are based in Stamford, CT with sites in San Francisco, CA and Boulder, CO. For more information about Loxo Oncology, please visit us at www.loxooncology.com.keywords:Biotechnology,Healthcare,Pharmaceuticals
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|The Scienomics ...||$18.5M||102||11%|
LOXO Oncology News
Pitcairn Co. decreased its position in Loxo Oncology Inc (NASDAQ:LOXO) by 6.8% during the 4th quarter, according to its most recent
Loxo Oncology Inc (NASDAQ:LOXO) has been assigned a consensus recommendation of “Buy” from the eighteen brokerages that are covering
Bristol-Myers Squibb to acquire Celgene, Eli Lilly to acquire Loxo Oncology ... history, and Eli Lilly and Co., which has agreed to acquire Loxo Oncology Inc.
LOXO Oncology Funding
|2014-05-07||$24.0M||B||New Enterprise Associates||Article|
LOXO Oncology Executive Hires
|2014-05-07||Mikel Moyer||Chief Scientific Officer||Article|
|2014-10-29||Jennifer Low||Chief Medical Officer/EVP R/D||Article|